Mass General Brigham Cancer Institute Accelerates Bold Vision for Patient-Centered Cancer Care

Mass General Brigham, the nation’s largest hospital-based research enterprise and home to two of the nation’s leading hospitals for cancer care, announced significant progress this week on its patient-centered vision for cancer care, initially announced a year ago.

The system has achieved key milestones in clinical outcomes, developing top-tier facilities, and multidisciplinary care, aimed at delivering seamless, high-quality care for patients in New England and beyond.

“Cancer touches every specialty, every family, and every part of the human body. At Mass General Brigham, it also unites us—clinicians, researchers, and caregivers—around a shared mission: to lead, to heal, and to transform,” said Anne Klibanski, MD, President and CEO, Mass General Brigham.

“At Mass General Brigham Cancer Institute, we have a bold vision to prevent and cure cancer on behalf of the communities we serve and people around the globe, and, as a world-class healthcare system with enormous scale and expertise, we are uniquely positioned to deliver on that vision,” said David Ryan, MD, President, Mass General Brigham Cancer Institute. “Every day, our experts drive breakthroughs and innovations, collaborating as one multidisciplinary team to shape the future of cancer—today.”

The Cancer Institute brings together the scale, expertise, and geographic reach of Massachusetts General Hospital, Brigham and Women’s Hospital, and the system’s broad network of community hospitals, affiliates and healthcare centers, to create a unified model of care.

This week, the system launched the next phase of its public campaign and began to embrace a single identity, beginning a process to retire the Mass General Cancer Center brand and evolve to the Mass General Brigham Cancer Institute name, with Brigham locations to follow in the near future. Coordinated, seamless patient care remains paramount throughout the transition.

Leading in Outcomes and Innovation

Mass General Brigham’s unified patient care strategy, For Every Patient, is driving superior clinical outcomes. In the latest U.S. News & World Report rankings measuring patient outcomes, MGH and BWH (with DFCI) ranked as the top two hospitals in New England and among the top 5 nationally for cancer. This builds on ongoing progress in key quality metrics like inpatient mortality, where the system outpaces local and national peers.

World-Class Spaces to Heal and Thrive

With a vast network of owned and affiliated sites across Massachusetts and New Hampshire, Mass General Brigham meets our patients where they are—today. New spaces are also underway, including new infusion and multidisciplinary clinical space at the Herb Chambers Tower on the MGH campus, and new cancer capabilities at the Hale Building for Transformative Medicine on the Brigham campus. These new spaces will begin to come online in the coming months and years, as the system maximizes its existing and future footprint to support cancer care and research 

Multidisciplinary, Expert Care

With 80% of cancers requiring surgery, Mass General Brigham performs more cancer surgeries than any other provider in New England. Its multidisciplinary model integrates surgical, medical oncology, and radiation expertise, supported by specialists in radiology, pathology, cardiology, psychiatry, and more. In recent months, new leaders have been named to drive this work—including top surgeons, radiation oncologists and medical oncologists from BWH, MGH, and beyond.

Pioneering Research

With $443 million in cancer research funding and more than 1,000 active clinical trials, Mass General Brigham leads the future of cancer innovation. At next week’s World Medical Innovation Forum, the system’s top cancer researchers and experts will share insights about the latest treatments in oncology care—from early detection and treatment, to rapid therapeutic development and emerging treatments in lung and hematological cancers.

“Because of our renowned clinicians, researchers, and staff, Mass General Brigham is a force in cancer care and innovation regionally, nationally, and globally,” said Dr. Klibanski. “Our excellence today is the foundation for our greater impact tomorrow.”